Insulet Corp.
PODD
Rang in aandelen
#2095
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aandeelprijs
$141.47
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$9.81B
Verandering (1 dag)
0.26%
Verandering (1 jaar)
-56.72%
Land
US
Handel Insulet Corp. (PODD)
Categorie
Healthcare
Winst voor Insulet Corp. (PODD)
Winst in Jun 2026 TTM: $494.70M
Volgens de meest recente financiële verslagen van Insulet Corp. bedraagt de huidige winst van het bedrijf $494.70M. In 2023 behaalde het bedrijf een winst van $214.60M, een stijging ten opzichte van de winst van 2022, die $9.80M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Insulet Corp. van 2002 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $494.70M | 64.79% |
| 2024 | $300.20M | 39.89% |
| 2023 | $214.60M | 2,089.80% |
| 2022 | $9.80M | -52.20% |
| 2021 | $20.50M | 111.34% |
| 2020 | $9.70M | -33.10% |
| 2019 | $14.50M | 178.85% |
| 2018 | $5.20M | -119.55% |
| 2017 | $-26.60M | -0.81% |
| 2016 | $-26.82M | -56.32% |
| 2015 | $-61.39M | 28.22% |
| 2014 | $-47.88M | 6.70% |
| 2013 | $-44.87M | -13.13% |
| 2012 | $-51.66M | -9.45% |
| 2011 | $-57.04M | -6.73% |
| 2010 | $-61.16M | -15.46% |
| 2009 | $-72.34M | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | 1,418.29% |
US
|
|
| $5.56B | 1,024.52% |
IE
|
|
| $5.15B | 940.63% |
US
|
|
| $3.86B | 680.47% |
US
|
|
| - | - |
DE
|
